InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.057 0.003 (5%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Change in substantial holding 20 Dec 2016 1:17PM $0.485 $0.057 fallen by 88.25%
$18 Change of Director's Interest Notice - ID 20 Dec 2016 1:15PM $0.485 $0.057 fallen by 88.25%
$18 Change of Director's Interest Notice - GK 20 Dec 2016 1:15PM $0.485 $0.057 fallen by 88.25%
$18 Market Capitalisation - further update 20 Dec 2016 1:13PM $0.485 $0.057 fallen by 88.25%
$18 Appendix 3B 20 Dec 2016 1:12PM $0.485 $0.057 fallen by 88.25%
$18 Market Capitalisation Update 19 Dec 2016 5:56PM $0.475 $0.057 fallen by 88%
$18 Results of Meeting 23 Nov 2016 11:48AM $0.860 $0.057 fallen by 93.37%
$18 Breakthrough in Delivering Idronoxil into Brain 23 Nov 2016 8:57AM $0.650 $0.057 fallen by 91.23%
$18 Corporate Presentation Updated 22 Nov 2016 10:29AM $0.550 $0.057 fallen by 89.64%
$18 Corporate Presentation 22 Nov 2016 9:58AM $0.520 $0.057 fallen by 89.04%
$18 Corporate Presentation Providing Clinical Program Guidance 22 Nov 2016 9:57AM $0.520 $0.057 fallen by 89.04%
$18 Medical Advisors Appointed for Extensive Clinical Program 17 Nov 2016 9:32AM $0.440 $0.057 fallen by 87.05%
$18 Change in substantial holding DH 14 Nov 2016 7:27PM $0.355 $0.057 fallen by 83.94%
$18 Appendix 4C - quarterly 31 Oct 2016 7:06PM $0.320 $0.057 fallen by 82.19%
$18 Initial Clinic Study Announced and Approved 26 Oct 2016 8:32AM $0.185 $0.057 fallen by 69.19%
$18 Noxopharm 2016 AGM Sydney Briefing 24 Oct 2016 3:17PM $0.185 $0.057 fallen by 69.19%
$18 Notice of 2016 AGM and 2016 Annual Report 21 Oct 2016 1:07PM $0.200 $0.057 fallen by 71.50%
$18 Corporate Presentation 20 Oct 2016 6:53PM $0.200 $0.057 fallen by 71.50%
$18 Annual Report to shareholders 3 Oct 2016 8:06AM $0.175 $0.057 fallen by 67.43%
$18 Appendix 4G 3 Oct 2016 8:05AM $0.175 $0.057 fallen by 67.43%
$18 Amendment to Preliminary Final Report 30 Sep 2016 7:00PM $0.175 $0.057 fallen by 67.43%
$18 Corporate Presentation for Roadshow 12 Sep 2016 3:06PM $0.140 $0.057 fallen by 59.29%
$18 Preliminary Final Report 31 Aug 2016 5:06PM $0.180 $0.057 fallen by 68.33%
$18 Change in substantial holding 25 Aug 2016 8:29AM $0.190 $0.057 fallen by 70%
$18 Noxopharm to Initiate Radiotherapy Clinical Studies 22 Aug 2016 8:18AM $0.165 $0.057 fallen by 65.45%

751 - 775 of 799 results

Page 31 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.